APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Atracurium Besylate Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Atracurium Besylate Injection Market Outlook and Growth Opportunities 2026

Report ID 173968090421 December 2025196 pages

Choose your research edition.

Industry ResearchAtracurium Besylate Injection Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Atracurium Besylate Injection Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Atracurium Besylate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Atracurium Besylate Injection Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Atracurium Besylate Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Atracurium Besylate Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Atracurium Besylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Atracurium Besylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Atracurium Besylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Atracurium Besylate Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Atracurium Besylate Injection market include Qilu Pharma, Pfizer, Hengrui Medicine, GSK, SGPharma, Samarth Life Sciences, Lexicare Pharma, HBM Pharma and Gland Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Atracurium Besylate Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Atracurium Besylate Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Atracurium Besylate Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Atracurium Besylate Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Atracurium Besylate Injection Segment by Company

Qilu Pharma

Pfizer

Hengrui Medicine

GSK

SGPharma

Samarth Life Sciences

Lexicare Pharma

HBM Pharma

Gland Pharma

Flagship Biotech

Centurion Healthcare

American Remedies Healthcare

Atracurium Besylate Injection Segment by Type

2.5ml:12.5mg

5ml:25mg

Atracurium Besylate Injection Segment by Application

Surgery

Medical Examination

Atracurium Besylate Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Atracurium Besylate Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Atracurium Besylate Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Atracurium Besylate Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Atracurium Besylate Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atracurium Besylate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Atracurium Besylate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atracurium Besylate Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Atracurium Besylate Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Atracurium Besylate Injection industry.

Chapter 3: Detailed analysis of Atracurium Besylate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Atracurium Besylate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Atracurium Besylate Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Atracurium Besylate Injection Industry Trends Table 2. Atracurium Besylate Injection Industry Drivers Table 3. Atracurium Besylate Injection Industry Opportunities and Challenges Table 4. Atracurium Besylate Injection Industry Restraints Table 5. Global Atracurium Besylate Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Atracurium Besylate Injection Revenue Share by Company (2021-2026) Table 7. Global Atracurium Besylate Injection Sales Volume by Company (L) & (2021-2026) Table 8. Global Atracurium Besylate Injection Sales Volume Share by Company (2021-2026) Table 9. Global Atracurium Besylate Injection Average Price (US$/ml) of Company (2021-2026) Table 10. Global Atracurium Besylate Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Atracurium Besylate Injection Key Company Manufacturing Base & Headquarters Table 12. Global Atracurium Besylate Injection Company, Product Type & Application Table 13. Global Atracurium Besylate Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Atracurium Besylate Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 2.5ml:12.5mg Table 18. Significant Companies of 5ml:25mg Table 19. Global Atracurium Besylate Injection Sales Volume by Type 2021 VS 2025 VS 2032 (L) Table 20. Global Atracurium Besylate Injection Sales Volume by Type (2021-2026) & (L) Table 21. Global Atracurium Besylate Injection Sales Volume by Type (2027-2032) & (L) Table 22. Global Atracurium Besylate Injection Sales Volume Share by Type (2021-2026) Table 23. Global Atracurium Besylate Injection Sales Volume Share by Type (2027-2032) Table 24. Global Atracurium Besylate Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Atracurium Besylate Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Atracurium Besylate Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Atracurium Besylate Injection Sales Value Share by Type (2021-2026) Table 28. Global Atracurium Besylate Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Surgery Table 30. Significant Companies of Medical Examination Table 31. Global Atracurium Besylate Injection Sales Volume by Application 2021 VS 2025 VS 2032 (L) Table 32. Global Atracurium Besylate Injection Sales Volume by Application (2021-2026) & (L) Table 33. Global Atracurium Besylate Injection Sales Volume by Application (2027-2032) & (L) Table 34. Global Atracurium Besylate Injection Sales Volume Share by Application (2021-2026) Table 35. Global Atracurium Besylate Injection Sales Volume Share by Application (2027-2032) Table 36. Global Atracurium Besylate Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Atracurium Besylate Injection Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Atracurium Besylate Injection Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Atracurium Besylate Injection Sales Value Share by Application (2021-2026) Table 40. Global Atracurium Besylate Injection Sales Value Share by Application (2027-2032) Table 41. Global Atracurium Besylate Injection Sales by Region: 2021 VS 2025 VS 2032 (L) Table 42. Global Atracurium Besylate Injection Sales by Region (2021-2026) & (L) Table 43. Global Atracurium Besylate Injection Sales Market Share by Region (2021-2026) Table 44. Global Atracurium Besylate Injection Sales by Region (2027-2032) & (L) Table 45. Global Atracurium Besylate Injection Sales Market Share by Region (2027-2032) Table 46. Global Atracurium Besylate Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Atracurium Besylate Injection Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Atracurium Besylate Injection Sales Value Share by Region (2021-2026) Table 49. Global Atracurium Besylate Injection Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Atracurium Besylate Injection Sales Value Share by Region (2027-2032) Table 51. Global Atracurium Besylate Injection Market Average Price (US$/ml) by Region (2021-2026) Table 52. Global Atracurium Besylate Injection Market Average Price (US$/ml) by Region (2027-2032) Table 53. Global Atracurium Besylate Injection Sales by Country: 2021 VS 2025 VS 2032 (L) Table 54. Global Atracurium Besylate Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Atracurium Besylate Injection Sales by Country (2021-2026) & (L) Table 56. Global Atracurium Besylate Injection Sales Market Share by Country (2021-2026) Table 57. Global Atracurium Besylate Injection Sales by Country (2027-2032) & (L) Table 58. Global Atracurium Besylate Injection Sales Market Share by Country (2027-2032) Table 59. Global Atracurium Besylate Injection Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Atracurium Besylate Injection Sales Value Market Share by Country (2021-2026) Table 61. Global Atracurium Besylate Injection Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Atracurium Besylate Injection Sales Value Market Share by Country (2027-2032) Table 63. Qilu Pharma Company Information Table 64. Qilu Pharma Business Overview Table 65. Qilu Pharma Atracurium Besylate Injection Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 66. Qilu Pharma Atracurium Besylate Injection Product Portfolio Table 67. Qilu Pharma Recent Development Table 68. Pfizer Company Information Table 69. Pfizer Business Overview Table 70. Pfizer Atracurium Besylate Injection Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 71. Pfizer Atracurium Besylate Injection Product Portfolio Table 72. Pfizer Recent Development Table 73. Hengrui Medicine Company Information Table 74. Hengrui Medicine Business Overview Table 75. Hengrui Medicine Atracurium Besylate Injection Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 76. Hengrui Medicine Atracurium Besylate Injection Product Portfolio Table 77. Hengrui Medicine Recent Development Table 78. GSK Company Information Table 79. GSK Business Overview Table 80. GSK Atracurium Besylate Injection Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 81. GSK Atracurium Besylate Injection Product Portfolio Table 82. GSK Recent Development Table 83. SGPharma Company Information Table 84. SGPharma Business Overview Table 85. SGPharma Atracurium Besylate Injection Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 86. SGPharma Atracurium Besylate Injection Product Portfolio Table 87. SGPharma Recent Development Table 88. Samarth Life Sciences Company Information Table 89. Samarth Life Sciences Business Overview Table 90. Samarth Life Sciences Atracurium Besylate Injection Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 91. Samarth Life Sciences Atracurium Besylate Injection Product Portfolio Table 92. Samarth Life Sciences Recent Development Table 93. Lexicare Pharma Company Information Table 94. Lexicare Pharma Business Overview Table 95. Lexicare Pharma Atracurium Besylate Injection Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 96. Lexicare Pharma Atracurium Besylate Injection Product Portfolio Table 97. Lexicare Pharma Recent Development Table 98. HBM Pharma Company Information Table 99. HBM Pharma Business Overview Table 100. HBM Pharma Atracurium Besylate Injection Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 101. HBM Pharma Atracurium Besylate Injection Product Portfolio Table 102. HBM Pharma Recent Development Table 103. Gland Pharma Company Information Table 104. Gland Pharma Business Overview Table 105. Gland Pharma Atracurium Besylate Injection Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 106. Gland Pharma Atracurium Besylate Injection Product Portfolio Table 107. Gland Pharma Recent Development Table 108. Flagship Biotech Company Information Table 109. Flagship Biotech Business Overview Table 110. Flagship Biotech Atracurium Besylate Injection Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 111. Flagship Biotech Atracurium Besylate Injection Product Portfolio Table 112. Flagship Biotech Recent Development Table 113. Centurion Healthcare Company Information Table 114. Centurion Healthcare Business Overview Table 115. Centurion Healthcare Atracurium Besylate Injection Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 116. Centurion Healthcare Atracurium Besylate Injection Product Portfolio Table 117. Centurion Healthcare Recent Development Table 118. American Remedies Healthcare Company Information Table 119. American Remedies Healthcare Business Overview Table 120. American Remedies Healthcare Atracurium Besylate Injection Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 121. American Remedies Healthcare Atracurium Besylate Injection Product Portfolio Table 122. American Remedies Healthcare Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Atracurium Besylate Injection Distributors List Table 126. Atracurium Besylate Injection Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Atracurium Besylate Injection Product Image Figure 2. Global Atracurium Besylate Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Atracurium Besylate Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Atracurium Besylate Injection Sales (2021-2032) & (L) Figure 5. Global Atracurium Besylate Injection Sales Average Price (US$/ml) & (2021-2032) Figure 6. Global Atracurium Besylate Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 2.5ml:12.5mg Image Figure 10. 5ml:25mg Image Figure 11. Global Atracurium Besylate Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (L) Figure 12. Global Atracurium Besylate Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Atracurium Besylate Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Atracurium Besylate Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Atracurium Besylate Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Atracurium Besylate Injection Sales Value Share by Type (2021-2032) Figure 17. Surgery Image Figure 18. Medical Examination Image Figure 19. Global Atracurium Besylate Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (L) Figure 20. Global Atracurium Besylate Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Atracurium Besylate Injection Sales Volume Share by Application (2021-2032) Figure 22. Global Atracurium Besylate Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Atracurium Besylate Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Atracurium Besylate Injection Sales Value Share by Application (2021-2032) Figure 25. Global Atracurium Besylate Injection Sales by Region: 2021 VS 2025 VS 2032 (L) Figure 26. Global Atracurium Besylate Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Atracurium Besylate Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Atracurium Besylate Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Atracurium Besylate Injection Sales Value (2021-2032) & (US$ Million) Figure 30. North America Atracurium Besylate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Atracurium Besylate Injection Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Atracurium Besylate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Atracurium Besylate Injection Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Atracurium Besylate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Atracurium Besylate Injection Sales Value (2021-2032) & (US$ Million) Figure 36. South America Atracurium Besylate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Atracurium Besylate Injection Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Atracurium Besylate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Atracurium Besylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Atracurium Besylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Atracurium Besylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Atracurium Besylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Atracurium Besylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Atracurium Besylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Atracurium Besylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Atracurium Besylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Atracurium Besylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Atracurium Besylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Atracurium Besylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Atracurium Besylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Atracurium Besylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Atracurium Besylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Atracurium Besylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Atracurium Besylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Atracurium Besylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Atracurium Besylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Atracurium Besylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Atracurium Besylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Atracurium Besylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Atracurium Besylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Atracurium Besylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Atracurium Besylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Atracurium Besylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Atracurium Besylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Atracurium Besylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Atracurium Besylate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Atracurium Besylate Injection Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Atracurium Besylate Injection Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 2.5ml:12.5mg
  • 5ml:25mg
Applications
  • Surgery
  • Medical Examination
Companies covered
  • Qilu Pharma
  • Pfizer
  • Hengrui Medicine
  • GSK
  • SGPharma
  • Samarth Life Sciences
  • Lexicare Pharma
  • HBM Pharma
  • Gland Pharma
  • Flagship Biotech
  • Centurion Healthcare
  • American Remedies Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Atracurium Besylate Injection Sales Value (2021-2032)
  4. 1.2.2 Global Atracurium Besylate Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Atracurium Besylate Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Atracurium Besylate Injection Market Dynamics
  1. 2.1 Atracurium Besylate Injection Industry Trends
  2. 2.2 Atracurium Besylate Injection Industry Drivers
  3. 2.3 Atracurium Besylate Injection Industry Opportunities and Challenges
  4. 2.4 Atracurium Besylate Injection Industry Restraints
3 Atracurium Besylate Injection Market by Company
  1. 3.1 Global Atracurium Besylate Injection Company Revenue Ranking in 2025
  2. 3.2 Global Atracurium Besylate Injection Revenue by Company (2021-2026)
  3. 3.3 Global Atracurium Besylate Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Atracurium Besylate Injection Average Price by Company (2021-2026)
  5. 3.5 Global Atracurium Besylate Injection Company Ranking (2024-2026)
  6. 3.6 Global Atracurium Besylate Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Atracurium Besylate Injection Company Product Type and Application
  8. 3.8 Global Atracurium Besylate Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Atracurium Besylate Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Atracurium Besylate Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Atracurium Besylate Injection Market by Type
  1. 4.1 Atracurium Besylate Injection Type Introduction
  2. 4.1.1 2.5ml:12.5mg
  3. 4.1.2 5ml:25mg
  4. 4.2 Global Atracurium Besylate Injection Sales Volume by Type
  5. 4.2.1 Global Atracurium Besylate Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Atracurium Besylate Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Atracurium Besylate Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Atracurium Besylate Injection Sales Value by Type
  9. 4.3.1 Global Atracurium Besylate Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Atracurium Besylate Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Atracurium Besylate Injection Sales Value Share by Type (2021-2032)
5 Atracurium Besylate Injection Market by Application
  1. 5.1 Atracurium Besylate Injection Application Introduction
  2. 5.1.1 Surgery
  3. 5.1.2 Medical Examination
  4. 5.2 Global Atracurium Besylate Injection Sales Volume by Application
  5. 5.2.1 Global Atracurium Besylate Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Atracurium Besylate Injection Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Atracurium Besylate Injection Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Atracurium Besylate Injection Sales Value by Application
  9. 5.3.1 Global Atracurium Besylate Injection Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Atracurium Besylate Injection Sales Value by Application (2021-2032)
  11. 5.3.3 Global Atracurium Besylate Injection Sales Value Share by Application (2021-2032)
6 Atracurium Besylate Injection Regional Sales and Value Analysis
  1. 6.1 Global Atracurium Besylate Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Atracurium Besylate Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Atracurium Besylate Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Atracurium Besylate Injection Sales by Region (2027-2032)
  5. 6.3 Global Atracurium Besylate Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Atracurium Besylate Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Atracurium Besylate Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Atracurium Besylate Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Atracurium Besylate Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Atracurium Besylate Injection Sales Value (2021-2032)
  12. 6.6.2 North America Atracurium Besylate Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Atracurium Besylate Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Atracurium Besylate Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Atracurium Besylate Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Atracurium Besylate Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Atracurium Besylate Injection Sales Value (2021-2032)
  21. 6.9.2 South America Atracurium Besylate Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Atracurium Besylate Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Atracurium Besylate Injection Sales Value Share by Country, 2025 VS 2032
7 Atracurium Besylate Injection Country-level Sales and Value Analysis
  1. 7.1 Global Atracurium Besylate Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Atracurium Besylate Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Atracurium Besylate Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Atracurium Besylate Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Atracurium Besylate Injection Sales by Country (2027-2032)
  6. 7.4 Global Atracurium Besylate Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Atracurium Besylate Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Atracurium Besylate Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Atracurium Besylate Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Atracurium Besylate Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Atracurium Besylate Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Atracurium Besylate Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Atracurium Besylate Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Atracurium Besylate Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Atracurium Besylate Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Atracurium Besylate Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Atracurium Besylate Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Atracurium Besylate Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Atracurium Besylate Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Atracurium Besylate Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Atracurium Besylate Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Atracurium Besylate Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Atracurium Besylate Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Atracurium Besylate Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Atracurium Besylate Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Atracurium Besylate Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Atracurium Besylate Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Atracurium Besylate Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Atracurium Besylate Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Atracurium Besylate Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Atracurium Besylate Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Atracurium Besylate Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Atracurium Besylate Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Atracurium Besylate Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Atracurium Besylate Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Atracurium Besylate Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Atracurium Besylate Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Atracurium Besylate Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Qilu Pharma
  2. 8.1.1 Qilu Pharma Company Information
  3. 8.1.2 Qilu Pharma Business Overview
  4. 8.1.3 Qilu Pharma Atracurium Besylate Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Qilu Pharma Atracurium Besylate Injection Product Portfolio
  6. 8.1.5 Qilu Pharma Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Atracurium Besylate Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Atracurium Besylate Injection Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Hengrui Medicine
  14. 8.3.1 Hengrui Medicine Company Information
  15. 8.3.2 Hengrui Medicine Business Overview
  16. 8.3.3 Hengrui Medicine Atracurium Besylate Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hengrui Medicine Atracurium Besylate Injection Product Portfolio
  18. 8.3.5 Hengrui Medicine Recent Developments
  19. 8.4 GSK
  20. 8.4.1 GSK Company Information
  21. 8.4.2 GSK Business Overview
  22. 8.4.3 GSK Atracurium Besylate Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 GSK Atracurium Besylate Injection Product Portfolio
  24. 8.4.5 GSK Recent Developments
  25. 8.5 SGPharma
  26. 8.5.1 SGPharma Company Information
  27. 8.5.2 SGPharma Business Overview
  28. 8.5.3 SGPharma Atracurium Besylate Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 SGPharma Atracurium Besylate Injection Product Portfolio
  30. 8.5.5 SGPharma Recent Developments
  31. 8.6 Samarth Life Sciences
  32. 8.6.1 Samarth Life Sciences Company Information
  33. 8.6.2 Samarth Life Sciences Business Overview
  34. 8.6.3 Samarth Life Sciences Atracurium Besylate Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Samarth Life Sciences Atracurium Besylate Injection Product Portfolio
  36. 8.6.5 Samarth Life Sciences Recent Developments
  37. 8.7 Lexicare Pharma
  38. 8.7.1 Lexicare Pharma Company Information
  39. 8.7.2 Lexicare Pharma Business Overview
  40. 8.7.3 Lexicare Pharma Atracurium Besylate Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Lexicare Pharma Atracurium Besylate Injection Product Portfolio
  42. 8.7.5 Lexicare Pharma Recent Developments
  43. 8.8 HBM Pharma
  44. 8.8.1 HBM Pharma Company Information
  45. 8.8.2 HBM Pharma Business Overview
  46. 8.8.3 HBM Pharma Atracurium Besylate Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 HBM Pharma Atracurium Besylate Injection Product Portfolio
  48. 8.8.5 HBM Pharma Recent Developments
  49. 8.9 Gland Pharma
  50. 8.9.1 Gland Pharma Company Information
  51. 8.9.2 Gland Pharma Business Overview
  52. 8.9.3 Gland Pharma Atracurium Besylate Injection Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Gland Pharma Atracurium Besylate Injection Product Portfolio
  54. 8.9.5 Gland Pharma Recent Developments
  55. 8.10 Flagship Biotech
  56. 8.10.1 Flagship Biotech Company Information
  57. 8.10.2 Flagship Biotech Business Overview
  58. 8.10.3 Flagship Biotech Atracurium Besylate Injection Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Flagship Biotech Atracurium Besylate Injection Product Portfolio
  60. 8.10.5 Flagship Biotech Recent Developments
  61. 8.11 Centurion Healthcare
  62. 8.11.1 Centurion Healthcare Company Information
  63. 8.11.2 Centurion Healthcare Business Overview
  64. 8.11.3 Centurion Healthcare Atracurium Besylate Injection Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Centurion Healthcare Atracurium Besylate Injection Product Portfolio
  66. 8.11.5 Centurion Healthcare Recent Developments
  67. 8.12 American Remedies Healthcare
  68. 8.12.1 American Remedies Healthcare Company Information
  69. 8.12.2 American Remedies Healthcare Business Overview
  70. 8.12.3 American Remedies Healthcare Atracurium Besylate Injection Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 American Remedies Healthcare Atracurium Besylate Injection Product Portfolio
  72. 8.12.5 American Remedies Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Atracurium Besylate Injection Value Chain Analysis
  2. 9.1.1 Atracurium Besylate Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Atracurium Besylate Injection Sales Mode & Process
  6. 9.2 Atracurium Besylate Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Atracurium Besylate Injection Distributors
  9. 9.2.3 Atracurium Besylate Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst